About this trial
MyGENESIS-PATH is a self-guided digital psychoeducational intervention designed to support donor-conceived adults in navigating donor-conception-related information and uncertainty, DNA testing, identity, family relationships, disclosure, stigma, and expectations concerning donors and donor siblings.
This two-arm randomized pilot and feasibility trial will evaluate the feasibility and acceptability of delivering MyGENESIS-PATH and of conducting a future definitive randomized controlled trial. Sixty donor-conceived adults will be randomly allocated in a 1:1 ratio to immediate access to MyGENESIS-PATH or to a waitlist control condition.
Primary feasibility outcomes will assess recruitment, completion of the 4-week follow-up assessment, completeness of psychosocial outcome data, intervention uptake and completion, and completion of the immediate post-intervention feedback assessment. Intervention acceptability, usability, perceived usefulness, relevance, emotional manageability, and potential unwanted effects will be assessed among participants allocated to MyGENESIS-PATH.
Changes in perceived stress, psychological well-being, coping, and donor-conception-related identity from baseline to 4 weeks after randomization will be examined as exploratory outcomes. The study is not powered to detect definitive intervention effects.
Eligibility criteria
Qualifiers
Donor-conceived people
Aged 18 or over
Able to read and understand English
Provide informed consent
Disqualifiers
Previous participation in the MyGENESIS-PATH alpha-testing phase
Unable to provide informed consent
Unable to complete the online study procedures
Trial design
Treatments tested in this trial
- MyGENESIS Digital Psychoeducational Program
Treatment groups
Sponsors and collaborators
Universidade do Porto
Lead sponsor
Fundação para a Ciência e a Tecnologia
Collaborator